Comparison of bezafibrate and fenofibrate efficacy for managing canine hyperlipidemia: A retrospective review

The aim of this retrospective study was to compare the triglyceride- and cholesterol-lowering effects of bezafibrate and fenofibrate in dogs with fasting hyperlipidemia and to evaluate the additional benefit of concurrent low-fat dietary management. To our knowledge, this is the first clinical study to directly compare these two fibrates in dogs treated under comparable clinical conditions. Sixty-five client-owned dogs were classified into six groups according to treatment: bezafibrate monotherapy, bezafibrate with a low-fat diet, fenofibrate monotherapy, fenofibrate with a low-fat diet, low-fat diet alone, and untreated control. Changes in serum triglyceride and total cholesterol concentrations from baseline to the final follow-up were analyzed, and hepatic and renal biochemical markers were assessed to evaluate short-term tolerability. Both bezafibrate and fenofibrate produced marked reductions in serum triglyceride concentrations, with no significant difference between the two fibrates. Dogs receiving low-fat dietary management showed significantly greater triglyceride reduction than those managed without low-fat dietary management, whereas total cholesterol changes did not differ significantly between treatment groups. Treatment duration was not significantly associated with the magnitude of lipid reduction. Hepatic and renal biomarkers remained stable during the follow-up period, and no serious adverse events were recorded. These findings indicate no significant difference in short-term triglyceride reduction between bezafibrate and fenofibrate in the studied population. Concurrent low-fat dietary management was associated with greater triglyceride reduction and should be considered an important component of treatment. Further prospective studies with larger populations and longer follow-up periods are needed to confirm long-term safety and efficacy..

Authors

Publication Details

Journal
Medycyna Weterynaryjna
Published
2026-11-15
DOI
https://doi.org/10.21521/mw.7206
Primary Topic
Veterinary Medicine and Surgery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparison of bezafibrate and fenofibrate efficacy for managing canine hyperlipidemia: A retrospective review

Soo-Yeon Jeong, SEUNG HAK YEO, CHUL PARK
Medycyna Weterynaryjna
Veterinary Medicine and Surgery
article

Comparison of bezafibrate and fenofibrate efficacy for managing canine hyperlipidemia: A retrospective review

Soo-Yeon Jeong, SEUNG HAK YEO, CHUL PARK
article en

Abstract

The aim of this retrospective study was to compare the triglyceride- and cholesterol-lowering effects of bezafibrate and fenofibrate in dogs with fasting hyperlipidemia and to evaluate the additional benefit of concurrent low-fat dietary management. To our knowledge, this is the first clinical study to directly compare these two fibrates in dogs treated under comparable clinical conditions. Sixty-five client-owned dogs were classified into six groups according to treatment: bezafibrate monotherapy, bezafibrate with a low-fat diet, fenofibrate monotherapy, fenofibrate with a low-fat diet, low-fat diet alone, and untreated control. Changes in serum triglyceride and total cholesterol concentrations from baseline to the final follow-up were analyzed, and hepatic and renal biochemical markers were assessed to evaluate short-term tolerability. Both bezafibrate and fenofibrate produced marked reductions in serum triglyceride concentrations, with no significant difference between the two fibrates. Dogs receiving low-fat dietary management showed significantly greater triglyceride reduction than those managed without low-fat dietary management, whereas total cholesterol changes did not differ significantly between treatment groups. Treatment duration was not significantly associated with the magnitude of lipid reduction. Hepatic and renal biomarkers remained stable during the follow-up period, and no serious adverse events were recorded. These findings indicate no significant difference in short-term triglyceride reduction between bezafibrate and fenofibrate in the studied population. Concurrent low-fat dietary management was associated with greater triglyceride reduction and should be considered an important component of treatment. Further prospective studies with larger populations and longer follow-up periods are needed to confirm long-term safety and efficacy..

Medycyna WeterynaryjnaVol. 83(1)
Veterinary Medicine and Surgery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Comparison of bezafibrate and fenofibrate efficacy for managing canine hyperlipidemia: A retrospective review — Soo-Yeon Jeong, SEUNG HAK YEO, et al. · Medycyna Weterynaryjna (2026) | TGRS Research Map | TGRS